Citations

The following clinical studies and data sources support the efficacy claims presented on this site.

Pain & Anxiety Reduction

  1. Čeko, M., Baeuerle, T., Webster, L., Wager, T.D., & Lumley, M.A. (2024). The effects of virtual reality neuroscience-based therapy on clinical and neuroimaging outcomes in patients with chronic back pain: A randomized clinical trial. Pain, 165(8), 1860–1874. https://pubmed.ncbi.nlm.nih.gov/38466872/

  2. Garcia, L.M., Birckhead, B.J., Krishnamurthy, P., Sackman, J., Mackey, I.G., Louis, R.G., Salmasi, V., Maddox, T., & Darnall, B.D. (2021). An 8-week self-administered at-home behavioral skills-based virtual reality program for chronic low back pain: Double-blind, randomized, placebo-controlled trial. Journal of Medical Internet Research, 23(2), e26292. https://pubmed.ncbi.nlm.nih.gov/33484240/

Opioid Reduction & Cost Analysis

  1. Delshad, S.D., Almario, C.V., Fuller, G., Luong, D., & Spiegel, B.M.R. (2018). Economic analysis of implementing virtual reality therapy for pain among hospitalized patients. npj Digital Medicine, 1, 22. https://pubmed.ncbi.nlm.nih.gov/31304304/

FDA Authorization

  1. U.S. Food and Drug Administration (2021). De Novo Classification Request for EaseVRx. DEN210014. https://www.fda.gov/medical-devices/recently-approved-devices/easevrx-den210014

Additional Supporting Research

  1. Garza-Villarreal, E.A., et al. (2017). Music-induced analgesia in chronic pain conditions: A systematic review and meta-analysis. Pain Physician, 20(6), 373–382. https://pubmed.ncbi.nlm.nih.gov/28886344/

  2. Brady, B., Veljanova, I., Schabrun, S., & Chipchase, L. (2018). Integrating culturally informed approaches into physiotherapy assessment and treatment of chronic pain. BMJ Open, 8(6), e021999. https://pubmed.ncbi.nlm.nih.gov/29934396/